# Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mature-results-of-a-randomized-phase-ii-multicenter-study-of-exemestane-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert Paridaens,Luc Dirix,Caroline Lohrisch,L.V.A.M. Beex,M. Nooij,David Cameron,Laura Biganzoli,Tanja Čufer,Luc Duchateau,Anne Hamilton,J.P. Lobelle,Martine Piccart |
| Citations | 230 |
| DOI | 10.1093/annonc/mdg362 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2122095366 |
| PMID | 12954578 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Caroline Lohrisch](https://scholariq.org/researchers/caroline-lohrisch/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Paper topics

- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.